GlyCosmos Glycolipids
Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
| Database | Last Updated |
|---|---|
| ChEBI | February 3, 2022 |
| KEGG | February 3, 2022 |
| LIPID MAPS Structure Database | February 3, 2022 |
| LipidBank | February 3, 2022 |
| PubChem | February 3, 2022 |
| Main Class | Sub Class ▲ | LM ID | Common Name | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula |
|---|---|---|---|---|---|---|---|---|---|
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-3Galb1-4Glc- (Isoglobo series)
|
Cytolipin R(d18:1/20:0)
|
1282.812543
|
C64H118N2O23
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-3Galb1-4Glc- (Isoglobo series)
|
Cytolipin R(d18:1/22:0)
|
1310.843843
|
C66H122N2O23
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-3Galb1-4Glc- (Isoglobo series)
|
Cytolipin R(d18:1/24:0)
|
1338.875143
|
C68H126N2O23
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-3Galb1-4Glc- (Isoglobo series)
|
Cytolipin R(d18:1/26:0)
|
1366.906443
|
C70H130N2O23
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-3Galb1-4Glc- (Isoglobo series)
|
Cytolipin R(d18:1/24:1(15Z))
|
1336.859493
|
C68H124N2O23
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-3Galb1-4Glc- (Isoglobo series)
|
Cytolipin R(d18:1/26:1(17Z))
|
1364.890793
|
C70H128N2O23
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-3Galb1-4Glc- (Isoglobo series)
|
iGb5
|
|||||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-3Galb1-4Glc- (Isoglobo series)
|
iGb5(d18:1/16:0)
|
1388.802768
|
C66H120N2O28
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-3Galb1-4Glc- (Isoglobo series)
|
iGb5(d18:1/18:0)
|
1416.834068
|
C68H124N2O28
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-3Galb1-4Glc- (Isoglobo series)
|
iGb5(d18:1/20:0)
|
1444.865368
|
C70H128N2O28
|
Displaying entries 121 - 130 of 3908 in total
International Collaboration
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Acknowledgements
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
